Strategic partnership with Autobio Diagnostics Co., Ltd enables Hardy Diagnostics to become exclusive US supplier of a new rapid, one-step lateral flow assay that detects IgM and IgG antibodies to the SARS-CoV-2 virus
Bio-Rad's blood-based immunoassay test can help clinicians identify if an individual has developed antibodies against SARS-CoV-2, the virus associated with COVID-19
Bio-Rad offers a portfolio of recombinant, monoclonal anti-idiotypic antibodies and drug-target complex binders for the development of highly selective and sensitive assays